Chemotherapy-induced cardiotoxicity and mitigation
Chemotherapy-induced cardiotoxicity and mitigation is a topic indexed in ScholarIQ from OpenAlex.
What is known about Chemotherapy-induced cardiotoxicity and mitigation?
This cluster of papers focuses on the cardiotoxic effects of various cancer treatments, particularly anthracyclines and related drugs like doxorubicin and trastuzumab. It explores the molecular mechanisms, pharmacologic developments, early detection, prevention, and management of cardiotoxicity in cancer patients. The papers also discuss the long-term cardiovascular complications and survival outcomes in individuals undergoing these treatments.
How many works does Chemotherapy-induced cardiotoxicity and mitigation have?
Chemotherapy-induced cardiotoxicity and mitigation has 34,947 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Chemotherapy-induced cardiotoxicity and mitigation have?
Chemotherapy-induced cardiotoxicity and mitigation has 647,469 citations in the OpenAlex counts ScholarIQ stores.
What is the OpenAlex record for Chemotherapy-induced cardiotoxicity and mitigation?
The OpenAlex for Chemotherapy-induced cardiotoxicity and mitigation is on the source record.